An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 022311
Company: GENZYME

Summary Review

Products on NDA 022311

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
MOZOBIL	PLERIXAFOR	24MG/1.2ML (20MG/ML)	SOLUTION;SUBCUTANEOUS	Prescription	AP	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 022311

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
12/15/2008	ORIG-1	Approval	Type 1 - New Molecular Entity	PRIORITY; Orphan	Label (PDF) Letter (PDF) Review Summary Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022311lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022311s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022311s000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022311s000_SumR.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
09/21/2023	SUPPL-23	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022311s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/022311Orig1s023ltr.pdf
08/19/2020	SUPPL-22	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022311s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/022311Orig1s022ltr.pdf
05/30/2019	SUPPL-20	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022311s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022311Orig1s020ltr.pdf
12/01/2017	SUPPL-18	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022311s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/022311s018ltr.pdf
05/12/2016	SUPPL-17	Manufacturing (CMC)		Label is not available on this site.
08/04/2015	SUPPL-16	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022311s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022311Orig1s016ltr.pdf
12/04/2014	SUPPL-15	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022311s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/022311Orig1s015ltr.pdf
11/12/2013	SUPPL-14	Manufacturing (CMC)		Label is not available on this site.
06/04/2013	SUPPL-13	Labeling-Package Insert, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022311s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022311Orig1s013ltr.pdf
02/26/2013	SUPPL-12	Manufacturing (CMC)		Label is not available on this site.
06/14/2010	SUPPL-1	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022311s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022311s001ltr.pdf

Labels for NDA 022311

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
09/21/2023	SUPPL-23	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022311s023lbl.pdf
08/19/2020	SUPPL-22	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022311s022lbl.pdf
05/30/2019	SUPPL-20	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022311s020lbl.pdf
12/01/2017	SUPPL-18	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022311s018lbl.pdf
08/04/2015	SUPPL-16	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022311s016lbl.pdf
12/04/2014	SUPPL-15	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022311s015lbl.pdf
06/04/2013	SUPPL-13	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022311s013lbl.pdf
06/04/2013	SUPPL-13	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022311s013lbl.pdf
06/14/2010	SUPPL-1	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022311s001lbl.pdf
12/15/2008	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022311lbl.pdf

Therapeutic Equivalents for NDA 022311

MOZOBIL

SOLUTION;SUBCUTANEOUS; 24MG/1.2ML (20MG/ML)
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
MOZOBIL	PLERIXAFOR	24MG/1.2ML (20MG/ML)	SOLUTION;SUBCUTANEOUS	Prescription	Yes	AP	022311	GENZYME
PLERIXAFOR	PLERIXAFOR	24MG/1.2ML (20MG/ML)	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	215334	AMNEAL
PLERIXAFOR	PLERIXAFOR	24MG/1.2ML (20MG/ML)	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	205182	DR REDDYS
PLERIXAFOR	PLERIXAFOR	24MG/1.2ML (20MG/ML)	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	213672	EUGIA PHARMA
PLERIXAFOR	PLERIXAFOR	24MG/1.2ML (20MG/ML)	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	206644	GLAND PHARMA LTD
PLERIXAFOR	PLERIXAFOR	24MG/1.2ML (20MG/ML)	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	215698	MEITHEAL
PLERIXAFOR	PLERIXAFOR	24MG/1.2ML (20MG/ML)	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	211901	MSN
PLERIXAFOR	PLERIXAFOR	24MG/1.2ML (20MG/ML)	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	205197	TEVA PHARMS USA INC

Top